Published: 17 July 2015
Author(s): Nermin N. Salkic, Elmir Cickusic, Predrag Jovanovic, Mirela Basic Denjagic, Samra Iljazovic-Topcic, Milenko Bevanda, Sead Ahmetagic
Section: Original Article

The use of commercially available noninvasive markers for chronic hepatitis B (CHB) related fibrosis is not widely available in developing countries so clinicians in those countries frequently use free alternatives. We aimed to create an optimized algorithm for selection of patients with the highest probability for presence/absence of significant liver fibrosis and cirrhosis based on the use of multiple free scores.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.